Ticker
IBIOCompany Name
IBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 16K | 4% | $ 400K |
3/31/2025 | $ 159K | 42.4% | $ 375K |
12/31/2024 | $ -855K | 0% | $ 375K |
9/30/2024 | $ -856K | 0% | $ 175K |
6/30/2024 | $ -906K | 0% | $ 225K |
3/31/2024 | $ -1.04M | 0% | $ 50K |
12/31/2023 | $ -2.35M | 0% | $ 50K |
9/30/2023 | $ 609K | 1218% | $ 50K |
6/30/2023 | $ 3.14M | 0% | $ 0 |
3/31/2023 | $ 6.56M | 10757.38% | $ 61K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx / Revenues
(=) CapEx %
CapEx % for IBIO INC is calculated as follows: CapEx [ $ 1.71M ] / Revenues [ $ 1.94M ]
(=) CapEx % [ 87.99% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 2.85K |
---|---|
min | 0% |
max | 15.02% |
average | 3.47% |
median | 2.43% |
std | 3.27% |